D
69.89
2.24 (3.31%)
| Previous Close | 67.65 |
| Open | 67.65 |
| Volume | 3,966,079 |
| Avg. Volume (3M) | 5,795,374 |
| Market Cap | 27,407,730,688 |
| Price / Earnings (TTM) | 38.83 |
| Price / Earnings (Forward) | 28.57 |
| Price / Sales | 6.39 |
| Price / Book | 10.13 |
| 52 Weeks Range | |
| Earnings Date | 30 Oct 2025 |
| Profit Margin | 12.90% |
| Operating Margin (TTM) | 12.91% |
| Diluted EPS (TTM) | 1.33 |
| Quarterly Revenue Growth (YOY) | 12.50% |
| Quarterly Earnings Growth (YOY) | -28.00% |
| Total Debt/Equity (MRQ) | 113.97% |
| Current Ratio (MRQ) | 1.50 |
| Operating Cash Flow (TTM) | 964.10 M |
| Levered Free Cash Flow (TTM) | 509.04 M |
| Return on Assets (TTM) | 5.97% |
| Return on Equity (TTM) | 23.72% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | DexCom, Inc. | Bearish | Bearish |
AIStockmoo Score
-0.3
| Analyst Consensus | -0.5 |
| Insider Activity | 3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.5 |
| Average | -0.30 |
|
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 0.42% |
| % Held by Institutions | 97.10% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 90.00 (Argus Research, 28.77%) | Buy |
| Median | 77.00 (10.17%) | |
| Low | 68.00 (Evercore ISI Group, -2.70%) | Hold |
| Average | 77.86 (11.40%) | |
| Total | 5 Buy, 1 Hold, 1 Sell | |
| Avg. Price @ Call | 64.89 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 12 Jan 2026 | 71.00 (1.59%) | Sell | 70.98 |
| Bernstein | 09 Jan 2026 | 86.00 (23.05%) | Buy | 67.40 |
| Mizuho | 17 Dec 2025 | 78.00 (11.60%) | Buy | 65.75 |
| Citigroup | 11 Dec 2025 | 77.00 (10.17%) | Buy | 68.94 |
| Morgan Stanley | 02 Dec 2025 | 75.00 (7.31%) | Buy | 64.45 |
| 10 Nov 2025 | 63.00 (-9.86%) | Hold | 54.84 | |
| Evercore ISI Group | 25 Nov 2025 | 68.00 (-2.70%) | Hold | 61.69 |
| Argus Research | 07 Nov 2025 | 90.00 (28.77%) | Buy | 55.00 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BROWN MICHAEL JON | 74.00 | 74.00 | 4,470 | 330,780 |
| LEACH JACOB STEVEN | 74.00 | 74.00 | 5,252 | 388,648 |
| SAYER KEVIN R | 74.00 | 74.00 | 36,961 | 2,735,114 |
| STERN SADIE | 74.00 | 74.00 | 4,467 | 330,558 |
| SYLVAIN JEREME M | 74.00 | 74.00 | 4,471 | 330,854 |
| Aggregate Net Quantity | 55,621 | |||
| Aggregate Net Value ($) | 4,115,954 | |||
| Aggregate Avg. Buy ($) | 74.00 | |||
| Aggregate Avg. Sell ($) | 74.00 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SAYER KEVIN R | Officer | 29 Jan 2026 | Acquired (+) | 71,218 | 74.00 | 5,270,132 |
| SAYER KEVIN R | Officer | 29 Jan 2026 | Disposed (-) | 34,257 | 74.00 | 2,535,018 |
| SYLVAIN JEREME M | Officer | 29 Jan 2026 | Acquired (+) | 7,123 | 74.00 | 527,102 |
| SYLVAIN JEREME M | Officer | 29 Jan 2026 | Disposed (-) | 2,652 | 74.00 | 196,248 |
| BROWN MICHAEL JON | Officer | 29 Jan 2026 | Acquired (+) | 7,123 | 74.00 | 527,102 |
| BROWN MICHAEL JON | Officer | 29 Jan 2026 | Disposed (-) | 2,653 | 74.00 | 196,322 |
| STERN SADIE | Officer | 29 Jan 2026 | Acquired (+) | 7,123 | 74.00 | 527,102 |
| STERN SADIE | Officer | 29 Jan 2026 | Disposed (-) | 2,656 | 74.00 | 196,544 |
| LEACH JACOB STEVEN | Officer | 29 Jan 2026 | Acquired (+) | 8,310 | 74.00 | 614,940 |
| LEACH JACOB STEVEN | Officer | 29 Jan 2026 | Disposed (-) | 3,058 | 74.00 | 226,292 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |